黑料吃瓜群网

A new report by the has highlighted the barriers and enablers to the implementation of hospital-initiated post-discharge medication reviews in Australia.

, published in SHPA鈥檚 flagship (JPPR), identified barriers in both hospital and primary care, including time pressures, limited resources, low awareness of available review programs and updated rules.

Enablers included facilitation of hospital initiated medication reviews (HIMRs) via GP referral pathways, educational visiting and onsite GP and aged care pharmacist roles.

Currently, the (HMR) and (RMMR) programs exist in the

The report authors propose trial funding of Transition of Care Stewardship (ToCS) pharmacists in hospitals as a key driver of increased access to timely HIMRs, with additional funding forecast to build capacity of primary care pharmacists and maximise their role in improving medication safety of high-risk patients at care transitions.

鈥淭he role of a ToCS pharmacist working collaboratively with hospital doctors and GPs could ensure a safe discharge as bed pressures increase.

鈥淥ur vision is that a ToCS pharmacist will facilitate HIMRs and a 鈥榳arm handover鈥� of the medication-related information for at-risk patients transitioning from hospital to either home or residential aged care (including respite care),鈥� an SHPA representative said.

The report follows to support the identification and referral by hospital-based clinicians of high-risk patients, after successful advocacy resulted in changes to the 7CPA program rules to broaden the referral base to include specialist medical practitioners.

SHPA President Tom Simpson said聽the and subsequent expert report is emblematic of the organisation鈥檚 core focus on advancing expert, specialised pharmacist care that places the patient at the centre of collaborative care teams.

鈥淪HPA looks forward to working with partners in government, pharmacy and primary care to improve medication safety outcomes for aged care patients after they have been admitted to hospital.

鈥淚n particular, we look forward to ensuring implementation of hospital-initiated medication review (HIMR) pathways, and that ToCS pharmacists have appropriate and seamless touchpoints with the upcoming onsite , so that we can fully realise wraparound, patient-centred care.鈥�

Image credit: iStock.com/PeopleImages